Abacus Global Management, Inc.
ABX NYSE Investment Advice Financials FY2021βFY2025
What Abacus Global Management, Inc. does
No business description yet.
- Legal name
- Abacus Global Management, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 13, 2026
- Accession Β· CIK
- 0001628280-26-017775
0001814287
Revenue and margins
Abacus Global Management, Inc. had $235M of revenue in fiscal 2025, up 110.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$26.6M in fiscal 2025, β11.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Abacus Global Management, Inc. returned $63.3M to shareholders in fiscal 2025. The diluted share count rose 40.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Abacus Global Management, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.1M | $30.1M | $25.6M | $132M | $38.1M |
| Debt incl. finance leases | β | $0.0M | $0.0M | $381M | $406M |
| Net debt / EBITDA | β | β0.9x | β0.9x | 35.4x | 3.4x |
| Debt / equity | β | β | 0.0x | 0.9x | 1.0x |
| Interest coverage | β | 786.6x | 2.4x | β0.0x | 2.3x |
| Current ratio | 0.6x | 25.6x | 1.4x | 2.6x | 0.5x |
| Quick ratio | 0.6x | 25.6x | 1.4x | 2.6x | 0.5x |
| Total assets | $346M | $59.1M | $332M | $874M | $902M |
| Total liabilities | $29.2M | $30.9M | $168M | $451M | $479M |
| Shareholders' equity | β$28.2M | β$18.4M | $164M | $423M | $419M |
| Net debt (β = net cash) | β | β$30.1M | β$25.6M | $249M | $368M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 2 / 9 | 1 / 9 | 3 / 9 |
| Accruals ratio | 4.9% | 10.4% | 37.6% | 30.7% | 7.0% |
| Altman Z'' | β | 8.16 | 1.34 | 1.49 | 0.85 |
5 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | β | $44.7M | $66.4M | $112M | $235M |
| Gross profit | β | $38.8M | $59.9M | $101M | $206M |
| Operating income | β | $33.7M | $24.1M | β$0.9M | $88.8M |
| Interest expense | β | $0.0M | $9.9M | $18.3M | $38.8M |
| Pretax income | $15.8M | β$0.6M | β | β | β |
| Income tax | β | $0.9M | $1.5M | $5.5M | $15.4M |
| Net income | $15.8M | $31.7M | $9.5M | β$24.0M | $36.5M |
| Net income to common | $2.0M | $31.7M | $9.5M | β$24.0M | $36.1M |
| Diluted EPS | β | $0.63 | $0.16 | β$0.34 | $0.36 |
| Diluted shares | β | 0.05B | 0.06B | 0.07B | 0.10B |
| Cash flow | |||||
| Cash from operations | β$1.2M | $10.7M | β$64.0M | β$209M | β$25.7M |
| Capital expenditure | β | $0.0M | $0.2M | $0.8M | $0.9M |
| Free cash flow | β | $10.7M | β$64.2M | β$210M | β$26.6M |
| Depreciation and amortization | β | $0.0M | $3.4M | $7.9M | $18.6M |
| Stock-based compensation | $0.0M | $0.0M | $10.8M | $43.4M | $15.5M |
| Acquisitions | β | β | $0.0M | $2.4M | $1.6M |
| Share buybacks | β | $0.0M | $1.3M | $10.7M | $43.8M |
| Dividends paid | β | β | β | $0.0M | $19.6M |
| Dividends and buybacks | β | $0.0M | $1.3M | $10.7M | $63.3M |
| Balance sheet | |||||
| Cash and short-term investments | $0.1M | $30.1M | $25.6M | $132M | $38.1M |
| Total debt | β | $0.0M | $0.0M | $381M | $406M |
| Current assets | $0.9M | $33.3M | $31.8M | $160M | $69.6M |
| Current liabilities | $1.6M | $1.3M | $23.3M | $62.5M | $149M |
| Property and equipment, net | β | $0.0M | $0.4M | $1.0M | $1.6M |
| Goodwill | β | $0.0M | $140M | $238M | $253M |
| Intangible assets | β | $0.0M | $29.6M | $79.8M | $66.4M |
| Total assets | $346M | $59.1M | $332M | $874M | $902M |
| Total liabilities | $29.2M | $30.9M | $168M | $451M | $479M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | β$28.2M | β$18.4M | $164M | $423M | $419M |
| Margins | |||||
| Gross margin | β | 86.8% | 90.2% | 89.8% | 87.7% |
| Operating margin | β | 75.3% | 36.3% | β0.8% | 37.7% |
| EBITDA margin | β | 75.3% | 41.5% | 6.3% | 45.6% |
| Net margin | β | 70.9% | 14.3% | β21.4% | 15.5% |
| FCF margin | β | 23.9% | β96.7% | β187.3% | β11.3% |
| Returns | |||||
| Return on capital | β | β | 13.8% | β0.1% | 8.9% |
| Return on capital employed | β | 58.3% | 7.8% | β0.1% | 11.8% |
| Return on equity | β | β | 13.1% | β8.2% | 8.7% |
| Return on assets | 4.6% | 15.6% | 4.9% | β4.0% | 4.1% |
| Return on tangible equity | β | β | β | β22.8% | 36.4% |
| Growth | |||||
| Revenue growth | β | β | 48.5% | 68.6% | 110.2% |
| Net income growth | β | 100.0% | β70.0% | β351.8% | β |
| EPS growth | β | β | β74.6% | β312.5% | β |
| FCF growth | β | β | β700.7% | β | β |
| Share count change | β | β | 14.7% | 22.5% | 40.2% |
| Financial health | |||||
| Net debt / EBITDA | β | β0.9x | β0.9x | 35.4x | 3.4x |
| Debt / equity | β | β | 0.0x | 0.9x | 1.0x |
| Interest coverage | β | 786.6x | 2.4x | β0.0x | 2.3x |
| Current ratio | 0.6x | 25.6x | 1.4x | 2.6x | 0.5x |
| Quick ratio | 0.6x | 25.6x | 1.4x | 2.6x | 0.5x |
| Capital allocation | |||||
| Capex / revenue | β | 0.0% | 0.3% | 0.7% | 0.4% |
| Stock comp / revenue | β | 0.0% | 16.2% | 38.8% | 6.6% |
| Payouts / FCF | β | 0.0% | β | β | β |
| Quality scores | |||||
| Piotroski F-score | β | β | 2.0 | 1.0 | 3.0 |
| Altman Z'' | β | 8.2 | 1.3 | 1.5 | 0.9 |
| Accruals ratio | 4.9% | 10.4% | 37.6% | 30.7% | 7.0% |
Source: SEC EDGAR XBRL filings (CIK 0001814287). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.